Zdrowie i gospodarka · 03/07/2014

FDA Classifies Transcutaneous Electrical Nerve Stimulator for Headache Treatment as Class II Device with Special Controls

The US Food and Drug Administration (FDA) has classified the transcutaneous electrical nerve stimulator to treat headache into Class II, a category that requires special controls to ensure the device is safe and effective, according to the FDA's recent decision.